关键词:Anti-Human EGFR/p110, soluble,Anti-Human EGFR/p110, soluble,Anti-Human EGFR/p110, soluble,Anti-Human EGFR/p110, soluble,ReliaTech
产品名称:Anti-Human EGFR/p110, soluble-Anti-Human EGFR/p110, soluble
产品货号:102-PA12
产品规格:200ug
背景资料:The epidermal growth factor receptor (EGFR) subfamily of receptor tyrosine kinases comprises four members: EGFR (also known as HER1, ErbB1 or ErbB), ErbB2 (Neu, HER-2), ErbB3 (HER-3), and ErbB4 (HER-4). All family members are type I transmembrane glycoprotein that has an extracellular domain which contains two cysteine-rich domains separated by a spacer region that is involved in ligand-binding, and a cytoplasmic domain which has a membrane-proximal tyrosine kinase domain and a C-terminal tail with multiple tyrosine autophosphorylation sites. Previously the cloning and expression of a 3 kb alternative EGFR transcript which encodes a 110 kDa form of the receptor (sEGFR/p110) was reported. This receptor isoform is identical to the extracellular region of the full-length 170 kDa EGFR through amino acid 603; in addition, p110 sEGFR contains 78 unique carboxy-terminal amino acids. The sEGFR/p110 is associated with the cell membrane and can be released, allowing detection in human serum and plasma. The existence of this circulating sEGFR isoform stimulated investigation of its role as a potential circulating biomarker. Several studies suggest that alterations in sEGFR levels may be useful in cancer diagnosis and in monitoring disease recurrence and outcome, especially in patients with ovarian or breast cancer. The new polyclonal antibody may be useful in determining the expression, localization, and function of sEGFR/p110, and importantly will allow to distinguish between the expression of this receptor isoform and full length EGF receptor.
保存建议:Anti-Human EGFR/p110, soluble-Anti-Human EGFR/p110, soluble该Anti-Human EGFR/p110, soluble的详细信息查看ReliaTech提供的产品说明。
产品描述:Rabbit
点击:Anti-Human EGFR/p110, soluble-Anti-Human EGFR/p110, soluble查看更详细产品说明,更多应用、储存、价格、货期等信息请致电400-6800-868垂询ReliaTech中国区域授权总代理艾美捷科技有限公司。更多特色试剂盒、特色抗体以及特色试剂等产品评论,请点击查看艾美捷特色产品网站。
ReliaTech全称为受体配体技术有限公司 (Receptor Ligand Technologies GmbH),1999年成立,总部位于德国不伦瑞克,是一家后基因组生物技术公司。ReliaTech主要专注于受体和配体的发现与研究。此外,ReliaTech也开发应用于血管与淋巴管生成研究的相关高品质试剂。目前ReliaTech提供近2800款产品,产品线主要包括重组蛋白(细胞因子、生长因子、可溶性受体)、抗体、ELISA试剂盒等。
艾美捷科技与国内外优秀的生物试剂供应商优保持着密切的合作关系,目前已成为众多国际知名品牌的中国总代理或一级代理,主要包括:AAT Bioquest、Abbexa、Abnova、Agrisera、Atlas Antibodies、BellBrook、Biomatik、Biosensis、BioVendor、CalBioreagents、Cayman Chem、Cell Biolabs、Columbia Biosciences、Crystal Chem、Cytoskeleton、DIAsource、Duchefa、Ebba Biotech、Echelon Biosciences、ECM Biosciences、Enzo Life Sciences、Epigentek、Equitech-Bio、FabGennix、GeneCopoeia、Hycult Biotech、ichorbio、Icosagen、Immundiagnostik、ImmunoReagents、IQ Products、Jackson、LC Labs、LifeSensors、Lumiprobe、Mabtech、Matreya、Medkoo Biosciences、MyBioSource、Nanoprobe、Norgen Biotek、ProSci、ProSpec、ReliaTech、Rockland、SouthernBiotech、StressMarq、SySy、TRC、US Biological 等,可以在短时间内为用户提供专业的前沿资讯、完备的产品及物流服务。